On December 4th ODI Pharma provided an update regarding Poland’s expanding medical cannabis market. The market remains an important focus of the company’s strategy - recent regulatory changes, where Polish Glówny Inspektor Farmaceutyczny (Chief Pharmaceutical Inspectorate or ”GIF”) increased the total amount of medical cannabis permitted to be imported into Poland from 6 tons to approx. 11.3 tons, indicates that the market is one of the fastest-growing and most exciting within medical cannabis in Europe.

Länk till analysen